First Risperdal Trial Ends With Settlement

Six Cases Total Have Settled in the Litigation

, The Legal Intelligencer

   | 1 Comments

The first trial in which evidence was taken in the mass tort litigation over Risperdal, the antipsychotic drug that plaintiffs have claimed causes males to grow breasts, was settled as part of a group of five cases that resolved this week for undisclosed amounts, according to the plaintiffs' lawyers and a statement from the drugmakers.

This content has been archived. It is available exclusively through our partner LexisNexis®.

To view this content, please continue to LexisAdvance®.

Continue to LexisAdvance®

Not a LexisAdvance® Subscriber? Subscribe Now

Why am I seeing this?

LexisNexis® is now the exclusive third party online distributor of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® customers will be able to access and use ALM's content by subscribing to the LexisNexis® services via LexisAdvance®. This includes content from the National Law Journal®, The American Lawyer®, Law Technology News®, The New York Law Journal® and Corporate Counsel®, as well as ALM's other newspapers, directories, legal treatises, published and unpublished court opinions, and other sources of legal information.

ALM's content plays a significant role in your work and research, and now through this alliance LexisNexis® will bring you access to an even more comprehensive collection of legal content.

For questions call 1-877-256-2472 or contact us at customercare@alm.com

What's being said

  • LulaineRDLegalFunding

    It's great plaintiffs finally have a good deal they could settle for and not have to go through longer court cases. Risperdal has been an ongoing case for years now and typically these massive tort cases can go on for a longer time than this settlement coming about. This could be a bell weather settlement and it could act as a signal to the rest of the plaintiffs.

Comments are not moderated. To report offensive comments, click here.

Preparing comment abuse report for Article #1202573753392

Thank you!

This article's comments will be reviewed.